It is possible that IRF8 may modulate the expression of surface molecules on the tumor cells or the secretion of soluble factors from these tumors, which then in a tumor-extrinsic manner suppresses RORγt in neighboring T cells and their differentiation into Th17 cells. This evidence concerns the gene IRF8 and neoplasm.